Skip to content

ARELIN

Active
Private limited company (pre-2019)founded 1999active for 27 yearsElverdingestraat 23, 8900 Ieper, BelgiumKBO/BCE: BE 0465.745.401
Summary

ARELIN has been active since 1999 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3.6m and a net result of €557,912. Equity is growing by about 13% per year across the filed financial years. Its solvency ranks better than 72% of 2,960 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
Specialist medical practice
NACE 86220
#8 company by equity in Ypres, Health and social work sector1 site
Size
€4.4mtotal assets 2025
Equity
€3.6m
Profit
€557,912
Turnover not published (abbreviated format)
Financial health
94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Holdings
2
Accounts filed 31 days late0 of 5 deeds read
Why 94raises riskLatest accounts 31 days late; 2 of the last 3 latelowers riskSize: total assets €4.4mSector: Human health activities (NACE 86)Figures for financial year 2025 (filed 31-08-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 48% of its sector peers (NACE 86, small)
Financial strength · tick = 2024
Strong
Solvency 100=
equity 81.0% of total assets
Liquidity 55-10
short-term debt 18.2% · cash 8.0%
Profitability 84-2
return on assets 12.6%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,072 companies, NACE 86, small)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025highest value 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026
Credit of up to €330,000 on 30-day terms is acceptable
Liquidity ample (current ratio 3.51, compared with 10.14 in 2024; short-term debt: 18.2% and cash: 8% of total assets), and 19% of the assets are financed with debt.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small): better than 77% on solvency, 34% on liquidity, 63% on profitability and 20% on growth.

The bankruptcy probability was computed on 09-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
−lowers risk+raises risk○neutral
lowers risk · Size: total assets €4.4m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Latest accounts 31 days late; 2 of the last 3 late
NBB · filings
lowers risk · Figures for financial year 2025 (filed 31-08-2026)
NBB · annual accounts
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
31 days late
2024
21 days late
2023
50 days late
2022
13 days early
2021
26 days early
2020
51 days late
2019
2 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 16 days after the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 21 August (4 of the last 5 filed years within 34 days of that day).
Companies Code · seven months
Where today falls in the filing period
10-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · abbreviated…
  3. Annual accounts filedfinancial year 2023 · abbreviated…

Key points

  • Positive: Among the best 7% on equitysector median €369,815 · 2,960 companies €3.6m View
  • Positive: 7 profitable years in a rowprofit 2025: €557,912 7 years View
  • Active since 1999founded 29-03-1999 27 years View

By topic

Financials

Financial year
2025
Total assets
€4.4m
Profit
€557,912
Solvency
81.0%
Total assets▲ 12.9%
Net result
20192025
Go to Financials

Timeline

Events
31
Since
2000
Next accounts
by 31-07-2027
  1. 31-12-2023Liquidity more than quadruples
  2. 18-07-2023Annual accounts filed
  3. 05-07-2022Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company (pre-2019)
Activity
Specialist medical practiceNACE 86220
Founded
29-03-1999
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.